CODX Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Co Diagnostics
CODX Stock  USD 0.75  0.04  4.94%   
Co Diagnostics financial statements provide useful quarterly and yearly information to potential Co Diagnostics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Co Diagnostics financial statements helps investors assess Co Diagnostics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Co Diagnostics' valuation are summarized below:
Gross Profit
3.6 M
Market Capitalization
25.2 M
Enterprise Value Revenue
0.0639
Revenue
7.3 M
Earnings Share
(1.38)
We have found one hundred twenty available fundamental measures for Co Diagnostics, which can be analyzed and compared to other ratios and to its peers in the sector. All investors should make sure to validate all of Co Diagnostics latest market performance against the performance between 2010 and 2025 to make sure the company can sustain itself in the future. Market Cap is likely to rise to about 68.9 M in 2025, whereas Enterprise Value is likely to drop slightly above 23.2 M in 2025.

Co Diagnostics Total Revenue

7.44 Million

Check Co Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 18 M, Selling General Administrative of 17.2 M or Total Revenue of 7.4 M, as well as many indicators such as Price To Sales Ratio of 6.26, Dividend Yield of 0.0 or PTB Ratio of 0.5. CODX financial statements analysis is a perfect complement when working with Co Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Co Diagnostics Correlation against competitors.
For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.

Co Diagnostics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets115.1 M109.6 M42.9 M
Slightly volatile
Total Current Liabilities3.8 M6.6 M2.9 M
Slightly volatile
Accounts Payable1.8 M1.7 M499.8 K
Slightly volatile
Cash19.4 M17.2 M13.3 M
Slightly volatile
Cash And Short Term Investments70.7 M67.3 M26.4 M
Slightly volatile
Capital Surpluse106.8 M101.7 M36.8 M
Slightly volatile
Total Liabilities6.4 M10.7 M4.7 M
Slightly volatile
Total Current Assets38.2 M71.5 M28.6 M
Slightly volatile
Common Stock22.9 K32.5 K43.9 K
Slightly volatile
Property Plant Equipment3.1 M2.9 M928.4 K
Slightly volatile
Short and Long Term Debt Total2.1 M3.4 M1.5 M
Slightly volatile
Other Current Liabilities2.3 M2.8 M1.6 M
Slightly volatile
Property Plant And Equipment Net7.2 M6.9 M1.7 M
Slightly volatile
Non Current Assets Total40.1 M38.2 M12 M
Slightly volatile
Net Receivables361.5 K380.5 K2.5 M
Slightly volatile
Common Stock Total Equity21.9 K40 K19.1 K
Slightly volatile
Common Stock Shares Outstanding22.2 M33.7 M18.3 M
Slightly volatile
Long Term Debt Total387.4 K400.5 K468.1 K
Slightly volatile
Liabilities And Stockholders Equity56.2 M109.6 M39.2 M
Slightly volatile
Non Current Liabilities Total2.8 M4.1 M2 M
Slightly volatile
Other Current Assets1.9 M1.8 M726.4 K
Slightly volatile
Other Stockholder Equity98.1 M93.4 M34.6 M
Slightly volatile
Property Plant And Equipment Gross9.9 M9.5 M2.3 M
Slightly volatile
Short and Long Term Debt2 M2.2 M1.5 M
Slightly volatile
Short Term Debt2.5 M1.6 M2.1 M
Slightly volatile
Other Liabilities3.3 M5.3 M2.1 M
Slightly volatile
Current Deferred Revenue437.7 K416.8 K132.7 K
Slightly volatile
Inventory2.7 M1.9 M1.4 M
Slightly volatile
Deferred Long Term Liabilities3.6 M2.8 M2.6 M
Slightly volatile
Net Invested Capital64.1 M98.9 M37.4 M
Slightly volatile
Long Term Investments671.4 K889.4 K384.2 K
Slightly volatile
Capital Stock30 K41.5 K21.2 K
Slightly volatile
Non Current Liabilities Other1.7 M860.3 K863.9 K
Slightly volatile

Co Diagnostics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative17.2 M16.4 M6.1 M
Slightly volatile
Research Development27.7 M26.4 M7.5 M
Slightly volatile
Total Operating Expenses54.7 M52.1 M17.2 M
Slightly volatile
Interest Income1.3 M1.2 M320.3 K
Slightly volatile
Selling And Marketing Expenses4.3 M7.9 M3.1 M
Slightly volatile
Other Operating Expenses59.8 M56.9 M20.4 M
Slightly volatile
Reconciled Depreciation1.5 M1.4 M395.2 K
Slightly volatile
Non Recurring12.3 M13.8 M15.1 M
Slightly volatile

Co Diagnostics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation1.5 M1.4 M387.4 K
Slightly volatile
Capital Expenditures1.6 M1.6 M495.6 K
Slightly volatile
End Period Cash Flow19.4 M17.2 M13.3 M
Slightly volatile
Change To Netincome25.4 M24.2 M6.7 M
Slightly volatile
Stock Based Compensation10.1 M9.6 M3 M
Slightly volatile
Begin Period Cash Flow19.7 M26.4 M13 M
Slightly volatile
Other Non Cash Items502.9 K529.4 K938.5 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio6.266.592.9 K
Slightly volatile
Days Sales Outstanding19.3720.3998.7583
Slightly volatile
Average Payables1.2 M1.1 M477.7 K
Slightly volatile
Stock Based Compensation To Revenue1.341.4137.5596
Very volatile
Capex To Depreciation1.531.01.571
Pretty Stable
EV To Sales4.354.582.9 K
Slightly volatile
Inventory Turnover1.432.261.0275
Slightly volatile
Days Of Inventory On Hand1591675.6 K
Slightly volatile
Payables Turnover2.412.545.1176
Slightly volatile
Sales General And Administrative To Revenue2.292.4189.3352
Slightly volatile
Average Inventory3.9 M3.7 M1.5 M
Slightly volatile
Research And Ddevelopement To Revenue3.683.8849.8827
Slightly volatile
Capex To Revenue0.220.236.694
Slightly volatile
Cash Per Share1.891.80.8644
Slightly volatile
Days Payables Outstanding1411493.9 K
Very volatile
Current Ratio5.99.736.0427
Slightly volatile
Receivables Turnover19.4618.536.5088
Slightly volatile
Graham Number8.428.023.7122
Slightly volatile
Capex Per Share0.0440.04190.0169
Slightly volatile
Average Receivables4.1 M2.6 M3 M
Slightly volatile
Revenue Per Share0.20.210.4958
Slightly volatile
Interest Debt Per Share0.140.09170.1813
Slightly volatile
Debt To Assets0.03430.03611.347
Slightly volatile
Operating Cycle1781875.7 K
Slightly volatile
Days Of Payables Outstanding1411493.9 K
Very volatile
Ebt Per Ebit0.90.81.0674
Very volatile
Quick Ratio5.569.475.7417
Slightly volatile
Net Income Per E B T0.981.070.9581
Pretty Stable
Cash Ratio2.872.343.0118
Slightly volatile
Days Of Inventory Outstanding1591675.6 K
Slightly volatile
Days Of Sales Outstanding19.3720.3998.7583
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.221.0214
Pretty Stable
Fixed Asset Turnover0.971.029.1244
Slightly volatile
Debt Ratio0.03430.03611.347
Slightly volatile
Price Sales Ratio6.266.592.9 K
Slightly volatile
Asset Turnover0.06110.06430.1513
Slightly volatile

Co Diagnostics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap68.9 M35.1 M71.8 M
Pretty Stable
Enterprise Value23.2 M24.4 M57.8 M
Very volatile

CODX Fundamental Market Drivers

Forward Price Earnings16
Cash And Short Term Investments58.5 M

CODX Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Co Diagnostics Financial Statements

Co Diagnostics investors use historical fundamental indicators, such as Co Diagnostics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Co Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue416.8 K437.7 K
Total Revenue7.8 M7.4 M
Cost Of Revenue4.8 M4.2 M
Stock Based Compensation To Revenue 1.41  1.34 
Sales General And Administrative To Revenue 2.41  2.29 
Research And Ddevelopement To Revenue 3.88  3.68 
Capex To Revenue 0.23  0.22 
Revenue Per Share 0.21  0.20 
Ebit Per Revenue(5.64)(5.92)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
EBRCentrais Electricas Brasileiras
HEHawaiian Electric Industries
VFCVF Corporation

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY